Skip to main content

Table 6 Type of pathology with different variables

From: Role of transvaginal ultrasound in detection of endometrial changes in breast cancer patients under hormonal therapy

 

Polyp (no. = 7)

Atrophy (no. = 3)

Hyperplasia (no. = 7)

Carcinoma (no. = 2)

Adenomyosis (no. = 5)

Test value

p value

Sig.

Age (years)

Mean ± SD

47.83 ± 4.40

44.00 ± 1.41

49.71 ± 3.90

52.50 ± 2.12

42.40 ± 5.32

3.290

0.036

S

Range

40–52

43–45

45–55

51–54

37–50

Hormonal (year)

Mean ± SD

3.64 ± 1.65

2.33 ± 0.58

2.79 ± 0.70

3.75 ± 1.77

1.40 ± 0.42

3.438

0.028

S

Range

1–5

2–3

2–4

2.5–5

1–2

Atypical vaginal bleeding

No

4 (57.14%)

0 (0.0%)

6 (85.71%)

0 (0.0%)

5 (100%)

13.029

0.011

S

Yes

3 (42.85%)

3 (100%)

1 (14.29%)

2 (100.0%)

0 (0.0%)

US-endo. thickness (mm)

Mean ± SD

14.64 ± 1.49

7.0 ± 6.08

16.71 ± 2.20

27.50 ± 3.54

9.76 ± 1.00

23.356

0.000

HS

Range

13–17

3–14

12.5–19

25–30

8.60–11

US-endo. regular

No

0 (00%)

3 (100%)

0 (0.0%)

2 (100.0%)

5(100%)

6.507

0.164

NS

Yes

7 (100.0%)

0 (0.0%)

7 (100.0%)

0 (0.0%)

0 (0.0%)